enVVeno Medical Corp NVNO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
4.62quote price arrow down-0.16 (-3.35%)
Volume
70,683
52 week range
2.51 - 6.97
Loading...
  • Open4.86
  • Day High4.89
  • Day Low4.57
  • Prev Close4.78
  • 52 Week High6.97
  • 52 Week High Date02/29/24
  • 52 Week Low2.51
  • 52 Week Low Date06/07/23

Key Stats

  • Market Cap61.525M
  • Shares Out13.32M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta1.13
  • YTD % Change-10.12

KEY STATS

  • Open4.86
  • Day High4.89
  • Day Low4.57
  • Prev Close4.78
  • 52 Week High6.97
  • 52 Week High Date02/29/24
  • 52 Week Low2.51
  • 52 Week Low Date06/07/23
  • Market Cap61.525M
  • Shares Out13.32M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta1.13
  • YTD % Change-10.12

RATIOS/PROFITABILITY

  • EPS (TTM)-1.96
  • P/E (TTM)-2.36
  • Fwd P/E (NTM)-3.28
  • EBITDA (TTM)-25.018M
  • ROE (TTM)-55.38%
  • Revenue (TTM)-
  • Gross Margin (TTM)49.37%
  • Net Margin (TTM)-24,409.09%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On enVVeno Medical Corp

 

Profile

MORE
enVVeno Medical Corporation is a late-stage clinical med-tech company. The Company is focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The Company is developing surgical and non-surgical replacement venous valves for patients suffering from severe Chronic Venous Insufficiency (CVI) of the deep venous system of the leg. The Company's lead product, VenoValve, which is a porcine based...
Robert Berman
Chief Executive Officer, Director
Craig Glynn
Chief Financial Officer, Treasurer
Address
70 Doppler
Irvine, CA
92618-4306
United States

Top Peers

SYMBOLLASTCHG%CHG
XAIR
Beyond Air Inc
1.23+0.04+3.36%
RBOT
Vicarious Surgical Inc
0.288+0.009+3.2258%
KNW
Know Labs Inc
0.58-0.0142-2.3898%
BEAT
Heartbeam Inc
1.93-0.16-7.66%
MODD
Modular Medical Inc
1.63-0.07-4.12%